Cancer Drugs in China: Unaffordability and Policy Solutions

DOI

10.2991/assehr.k.211120.092How to use a DOI?

Keywords

cancer drug; China; affordability; policy; human welfare

Abstract

The high cost and unaffordability of cancer drugs present serious challenges to treatment access and cancer outcomes. This issue is particularly salient in developing countries, where health care provision is limited and patients are themselves responsible for a large portion of treatment costs. What are the various reasons for the high cost of cancer drugs? How do different countries respond to this challenge differently? What policies are already in place to address this challenge, and what additional issues remain to be addressed in the long term? This paper discusses these topics in the context of China through an economic and public-policy lens and suggests a few long-term solutions.

Copyright

© 2021 The Authors. Published by Atlantis Press SARL.

Open Access

This is an open access article under the CC BY-NC license.

Download article (PDF)

TY  - CONF
AU  - Yining Liu
PY  - 2021
DA  - 2021/11/29
TI  - Cancer Drugs in China: Unaffordability and Policy Solutions
BT  - Proceedings of the 2021 3rd International Conference on Literature, Art and Human Development (ICLAHD 2021)
PB  - Atlantis Press
SP  - 484
EP  - 488
SN  - 2352-5398
UR  - https://doi.org/10.2991/assehr.k.211120.092
DO  - 10.2991/assehr.k.211120.092
ID  - Liu2021
ER  -